Literature DB >> 17361031

The significance of Pin1 in the development of Alzheimer's disease.

Suqing Wang1, Brook P Simon, David A Bennett, Julie A Schneider, James S Malter, Deng-Shun Wang.   

Abstract

Pin1 protein, a peptidyl-prolyl cis-trans isomerase plays an important regulatory role in neuronal function. Recent studies indicate that Pin1 may promote the dephosphorylation of tau and restore its ability to bind to and polymerize microtubles. Previous studies on postmortem human brains showed that Pin1 is down-regulated in advanced Alzheimer's disease (AD) brains compared to age-matched non-demented controls. Because AD is a slowly progressive disease with a preclinical period that can last years, the abundance and regulatory function of Pin1 may vary on the course of the disease. In order to evaluate the potential contribution of Pin1 to AD pathogenesis, levels of mRNA, protein and isomerase activity of Pin1 and phosphorylated tau from postmortem brains of 10 persons with mild-cognitive impairment (MCI), 10 with AD and 10 age-matched no cognitive impairment (NCI) were measured. The relationship between Pin1 and phosphorylated tau as well as clinical and cognitive data were analyzed. The results indicated that Pin1 activity in MCI and AD were significantly higher than in NCI. Phosphorylated tau in MCI and AD was also higher than in NCI group. The positive correlation trend in MCI and the robust correlation in AD between Pin1 activity and phosphorylated tau implies that increasing phosphorylated tau during AD pathogenesis may induce the compensatory activation/up-regulation of Pin1, while the inverse correlation between Pin1 activity and phosphorylated tau in NCI group implies that decreased Pin1 may play a role in the initial accumulation of phosphorylated tau in AD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17361031     DOI: 10.3233/jad-2007-11105

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  16 in total

1.  Prolyl isomerase Pin1 regulates neuronal differentiation via β-catenin.

Authors:  Kazuhiro Nakamura; Isao Kosugi; Daniel Y Lee; Angela Hafner; David A Sinclair; Akihide Ryo; Kun Ping Lu
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

2.  Altered NEP2 expression and activity in mild cognitive impairment and Alzheimer's disease.

Authors:  Jeffrey Y Huang; Daniel M Hafez; Bryan D James; David A Bennett; Robert A Marr
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 3.  Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Neurochem       Date:  2018-11-27       Impact factor: 5.372

4.  Overview and findings from the religious orders study.

Authors:  David A Bennett; Julie A Schneider; Zoe Arvanitakis; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

5.  Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology.

Authors:  Mark Yarchoan; Bryan D James; Raj C Shah; Zoe Arvanitakis; Robert S Wilson; Julie Schneider; David A Bennett; Steven E Arnold
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain.

Authors:  Suqing Wang; Rui Wang; Lang Chen; David A Bennett; Dennis W Dickson; Deng-Shun Wang
Journal:  J Neurochem       Date:  2010-07-30       Impact factor: 5.372

Review 7.  A common biological mechanism in cancer and Alzheimer's disease?

Authors:  M I Behrens; C Lendon; C M Roe
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

8.  N-acetylcysteine prevents 4-hydroxynonenal- and amyloid-beta-induced modification and inactivation of neprilysin in SH-SY5Y cells.

Authors:  Rui Wang; James S Malter; Deng-Shun Wang
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

9.  Effects of 4-hydroxy-nonenal and Amyloid-beta on expression and activity of endothelin converting enzyme and insulin degrading enzyme in SH-SY5Y cells.

Authors:  Rui Wang; Suqing Wang; James S Malter; Deng-Shun Wang
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Effects of HNE-modification induced by Abeta on neprilysin expression and activity in SH-SY5Y cells.

Authors:  Rui Wang; Suqing Wang; James S Malter; Deng-Shun Wang
Journal:  J Neurochem       Date:  2009-02       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.